Please ensure Javascript is enabled for purposes of website accessibility Venture Fund - Janus Henderson Investors
For Financial Professionals in the US

Venture Fund Holdings

Full Portfolio Holdings

(As of 07/31/2024)

% OF INVESTMENTS
SS&C Technologies Holdings Inc 2.09
Stride Inc 2.08
Descartes Systems Group Inc 1.83
Rentokil Initial PLC (ADR) 1.73
Globus Medical Inc 1.62
Blackbaud Inc 1.61
SPX Technologies Inc 1.55
Broadridge Financial Solutions Inc 1.54
Core & Main Inc 1.50
Sensient Technologies Corp 1.45
Vaxcyte Inc 1.43
Bancorp Inc 1.38
OSI Systems Inc 1.37
Valvoline Inc 1.35
Lantheus Holdings Inc 1.32
Tyler Technologies Inc 1.31
Glaukos Corp 1.25
Janus International Group Inc 1.22
Nice Ltd (ADR) 1.20
Constellium SE 1.19
Casey's General Stores Inc 1.18
CSW Industrials Inc 1.17
Euronet Worldwide Inc 1.13
Napco Security Technologies Inc 1.12
Madrigal Pharmaceuticals Inc 1.10
EnerSys 1.10
ON Semiconductor Corp 1.09
LPL Financial Holdings Inc 1.09
Shift4 Payments Inc 1.09
Zurn Elkay Water Solutions Corp 1.08
WEX Inc 1.07
ITT Inc 1.06
Alight Inc 1.02
ATS Corp 1.01
Gates Industrial Corp PLC 1.00
Magnolia Oil & Gas Corp 0.99
Paylocity Holding Corp 0.98
Ligand Pharmaceuticals Inc 0.96
Atlanta Braves Holdings Inc 0.95
Innospec Inc 0.95
CRA International Inc 0.91
ICU Medical Inc 0.89
Alamo Group Inc 0.88
Vertex Inc 0.87
Monarch Casino & Resort Inc 0.87
BellRing Brands Inc 0.86
Clarivate PLC 0.84
Altair Engineering Inc 0.81
Repay Holdings Corp 0.80
Insmed Inc 0.80
ICON PLC 0.78
Enpro Inc 0.78
STERIS PLC 0.77
WNS Holdings Ltd 0.77
Aramark 0.76
RLI Corp 0.76
Perimeter Solutions SA 0.75
Ziff Davis Inc 0.75
REVOLUTION Medicines Inc 0.73
NeoGenomics Inc 0.71
Loar Holdings Inc 0.71
CACI International Inc 0.71
Chart Industries Inc 0.69
Bio-Techne Corp 0.68
Baldwin Insurance Group Inc 0.65
PDF Solutions Inc 0.64
Gerresheimer AG 0.64
Ascendis Pharma A/S (ADR) 0.64
MACOM Technology Solutions Holdings Inc 0.62
Weatherford International PLC 0.60
Mirum Pharmaceuticals Inc 0.60
AvidXchange Holdings Inc 0.60
Novanta Inc 0.59
Walker & Dunlop Inc 0.59
Halozyme Therapeutics Inc 0.59
Avadel Pharmaceuticals PLC 0.58
Ideaya Biosciences Inc 0.58
AST SpaceMobile Inc 0.57
Biohaven Ltd 0.56
Colliers International Group Inc 0.55
FirstService Corp 0.55
Payfare Inc 0.55
HealthEquity Inc 0.54
CECO Environmental Corp 0.53
U-Haul Holding Co 0.52
Asure Software Inc 0.51
Doximity Inc 0.49
Oddity Tech Ltd 0.49
MSA Safety Inc 0.48
Bel Fuse Inc 0.48
Camtek Ltd/Israel 0.47
Williams-Sonoma Inc 0.46
Lovesac Co 0.46
Cognex Corp 0.46
Nordson Corp 0.45
Neogen Corp 0.45
Innodata Inc 0.44
Enfusion Inc 0.44
Consensus Cloud Solutions Inc 0.43
Montrose Environmental Group Inc 0.43
Brady Corp 0.41
Vivid Seats Inc 0.40
California Resources Corp 0.37
Avidity Biosciences Inc 0.36
Thor Industries Inc 0.36
Computer Modelling Group Ltd 0.36
PTC Therapeutics Inc 0.33
Kornit Digital Ltd 0.33
Sotera Health Co 0.32
Tandem Diabetes Care Inc 0.32
OmniAb Inc 0.32
indie Semiconductor Inc 0.32
Bridgebio Pharma Inc 0.31
Soleno Therapeutics Inc 0.31
Dyne Therapeutics Inc 0.30
Manchester United Plc 0.30
Xenon Pharmaceuticals Inc 0.30
Crinetics Pharmaceuticals Inc 0.30
Arcellx Inc 0.28
Xometry Inc 0.27
Paragon 28 Inc 0.27
Apartment List Inc 0.25
Wayfair Inc 0.25
UL Solutions Inc 0.23
Sarepta Therapeutics Inc 0.18
Janux Therapeutics Inc 0.18
89bio Inc 0.17
Ibotta Inc 0.17
Structure Therapeutics Inc (ADR) 0.16
Loadsmart Inc 0.15
Beacon Roofing Supply Inc 0.12
Edgewise Therapeutics Inc 0.10
IntelyCare Inc 0.07
Loadsmart Inc 0.05
Claris Ventures SGR SPA 0.01
OmniAb Operations Inc 0.01
OmniAb Operations Inc 0.01
Perimeter Solutions SA 0.00
Cash & Equivalents 1.78
Janus Henderson publishes this listing of securities held as of the most recently available disclosure period, which varies depending on the portfolio. Any portion of holdings may be excluded from publication when deemed in the best interest of the portfolio. Securities are reported at market value.
The portfolio data and its presentation here is based on the investment book of record and may differ from the accounting book of record and complete schedules of investments in regulatory filings due to differing accounting and reporting standards.